Epclusa for Hepatitis C

RS
Overseen ByRonda Shea
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Patrick Grace
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Breakthrough TherapyThis drug has been fast-tracked for approval by the FDA given its high promise

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will evaluate a single-visit approach to hepatitis C treatment in patients seen in the emergency department. Participants with hepatitis C will receive rapid testing and, if eligible, hepatitis C medication before leaving the emergency department. The study will also use a smart pillbox, an AI-powered virtual agent, and community health worker support to help participants take their medication as prescribed. Participants will have follow-up visits and testing to assess medication adherence and whether the hepatitis C infection is cured.

Are You a Good Fit for This Trial?

This trial is for people diagnosed with hepatitis C who visit the emergency department. Participants must be eligible to start treatment right away and able to use support tools like a smart pillbox and virtual assistant.

Inclusion Criteria

I am being discharged from the emergency department or observation unit.
I am between 22 and 65 years old and am getting antibody testing in the Emergency Department.

Exclusion Criteria

Followed by hospice or transplant with life expectancy < 1 year
I am unable to understand or agree to participate in this study.
Pregnancy
See 8 more

What Are the Treatments Tested in This Trial?

Interventions

  • Epclusa (sofosbuvir and velpatasvir)

Trial Overview

The study tests giving hepatitis C medication (Epclusa) during a single emergency room visit, supported by an AI-powered pillbox, virtual agent, and community health worker follow-up to help patients take their medicine correctly.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Medication in HandExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Patrick Grace

Lead Sponsor